Hollings Cancer Center Members

Breast Cancer Surgeon and Cancer Outcomes Research

Panomics, unique individual factors, and data science in cancer related health outcomes

My work mainly focuses on improving cancer outcomes and mitigating disparities among underserved communities, as well as increasing access to and utilization of cancer preventive services in vulnerable and minoritized populations.

Development of adjunct methods through mindful breathing to improve cancer survivorship

Alcohol and stress interactions that impact risk for and progression of various cancers.

My primary cancer-related research interests involve investigating the social-contextual and behavioral mechanisms underlying tobacco use and cessation to inform equitable prevention and intervention efforts that reduce tobacco-related cancer disparities.

Managing all aspects of basic, translational, and clinical research and the development of the research enterprise

Tobacco cessation

Studying ways to more rapidly disseminate evidence-based interventions to reduce the harms caused by tobacco use.

Optimizing equitable delivery of guideline concordant cancer care with an emphasis on postoperative venous thromboembolism prophylaxis

Development and evaluation of technology-based smoking cessation interventions for delivery within primary care

Cancer epidemiology and decision science, human papillomavirus, anal cancer, cervical cancer, oropharyngeal cancer

Bedside to bench to curbside (population) studies toward improving cancer diagnosis, treatment, prevention.

Improving cancer screening in primary care

Lung and esophageal cancer

My research focus is on developing and testing interventions to increase the participation of focal populations in cancer research and to increase adherence to evidence-based cancer prevention/control and treatment strategies.

Improving outcomes for patients with non-small cell lung cancer by improving utilization of biomarker testing that directs treatment decisions at the time of diagnosis, recurrence, and progression.

Human Papillomavirus (HPV)-related cancer prevention research

The development, evaluation, and implementation of multilevel interventions to improve the timeliness, equity, and quality of care delivery for patients with cancer along the care continuum

Cancer prevention via treatment development and clinical trials of interventions for tobacco, cannabis, and other substance use disorders

Identifying and managing patients with pathogenic variants in cancer susceptibility genes, and building clinical decision support tools to make care more efficient and effective

Develop, test, and disseminate psychosocial and behavioral interventions to improve symptom management and quality of life in cancer survivors.  

Identifying and addressing the psychosocial support needs of cancer caregivers.

As a member of the Biostatistics Shared Resource, I collaborate with Hollings investigators on a wide-range of grant and clinical trial development, including numerous investigator-initiated trials.

Non-invasive brain stimulation (e.g., transcranial magnetic stimulation) for smoking cessation in cancer patients

Application of epidemiologic methods to facilitate the translation of prostate cancer biomarkers into improved health outcomes

Tobacco/nicotine product cessation and strategies to improve long-term abstinence, including the role of cannabis co-use on tobacco cessation outcomes, as well as the study of cannabis use disorder and its treatment

Cannabis, co-use of cannabis and tobacco

My research focuses on assessing and improving care and outcomes for cancer survivors and their caregivers.

Biostatistics

Head and Neck Cancer / Minority Health Disparities

Methodological research using data science approaches on EHRs and SDOH to identify risks for health inequities and poor outcomes in cancer patients

I am interested in cancer prevention broadly, with specific expertise in developing and testing tobacco treatment interventions, exploring the potential for tobacco harm reduction, and assessing population-level prevalence of tobacco use behaviors.

Cancer control, namely, tobacco treatment interventions for populations with medical comorbidities and implementing tobacco treatment interventions in the healthcare system

Minimally invasive urologic oncology - laparoscopy and robotics

Racial prostate cancer disparities and the barriers that black men face to making informed decisions about prostate cancer screening

Screening for lung cancer, identifying biomarkers to reclassify risk of developing cancer, and lung nodule evaluation and management

Reducing tobacco use, a leading cause of cancer-related death and disease

Prevention and Control; Data Analytics and Visualization

Developing and testing digital health supportive care interventions to facilitate positive care transitions for cancer survivors and their caregivers while using implementation science principles to evaluate implementation processes

Lung cancer diagnostics with a focus on lung cancer screening implementation and the evaluation of biomarkers for early risk and nodule characterization

Preventing cancer through the development of novel therapeutics for tobacco and nicotine use

Understanding individual differences in cannabis and tobacco use to enhance treatment efforts

Racial differences in immune and microbial responses and risk and outcomes in colorectal cancer

Biobanking and independent research initiatives related to making genomic and family health history information more effectively used in health care